>
  info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Upper GI Series Companies

Upper GI Series companies are experts in diagnostic imaging, particularly for the upper gastrointestinal tract. They provide specialized radiological procedures, using contrast agents and X-rays to visualize the esophagus, stomach, and duodenum. These companies play a vital role in diagnosing various gastrointestinal conditions.

Upper Gastrointestinal Series Key Companies

 

Latest Upper Gastrointestinal Series Companies Update

Motus GI Receives FDA Clearance and Successfully Completes First Procedure for Pure-Vu® EVS Gastro:A significant development came in October 2023 when Motus GI, a company specializing in endoscopic visualization technology, received FDA clearance for its Pure-Vu® EVS Gastro system.


This innovative device is designed to improve visualization during upper GI procedures, particularly for addressing upper GI bleeds, a critical area with unmet needs.


Shortly after receiving clearance, Motus GI also announced the successful completion of the first patient procedure using Pure-Vu® EVS Gastro, marking a crucial milestone in bringing this technology to market.


Growing Adoption of AI-powered Solutions for Upper GI Analysis:Artificial intelligence (AI) is making waves in the medical field, and the Upper GI Series Market is no exception. Companies like GE Healthcare and Aidoc are developing AI algorithms that can analyze X-rays and other imaging data from upper GI series to detect abnormalities with greater accuracy and efficiency.


This technology has the potential to improve diagnostic accuracy, reduce procedure times, and ultimately lead to better patient outcomes.

 

List of Upper Gastrointestinal Series Key Companies in the Market


  • GastroIntestinal Specialists LLC. (UK)

  • Eisai Co. Ltd (Japan)

  • Cadila Pharmaceuticals Limited (India)

  • Purdue Pharma L.P. (US)

  • Alfa Wassermann SPA (Germany)

  • Novadaq Technologies Inc. (Canada)

  • AstraZeneca (UK)

  • Ironwood Pharmaceuticals Inc. (US)


 

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.